First New Osteoporosis Medicine Approved in the European Union (EU) Since 2010
Novel Bone-Builder With a Dual Effect That Increases Bone Formation and Reduces Bone Loss
PR Newswire
THOUSAND OAKS, Calif. and BRUSSELS, Dec. 11, 2019
PR Newswire
THOUSAND OAKS, Calif. and BRUSSELS, Dec. 11, 2019
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey